Common Stock
- Symbol
- YCBD
- Exchange
- NYSE
- Classification
- COMMON
- Status
- Current
Current Report · Items 8.01 · 8-K
cbdMD, Inc.
YCBDNYSE_AMERICANEQUITYCurrent
Other Events
Item 8.01 Other Events. On April 14, 2026, the board of directors (the “Board”) of cbdMD, Inc. (the “Company”) issued each independent director and the non-management employee director 1,572 of the Company restricted stock units (the “RSUs”) as compensation for services as a director for the term beginning on March 31, 2026.…
Company context
Current securities
Historical securities (1)
Recent company filings
- Completion of Acquisition or Disposition of Assets · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Unregistered Sales of Equity Securities · Regulation FD Disclosure · Other EventsNov 4, 2026
- Entry into a Material Definitive Agreement · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD DisclosureSep 2, 2026
- 10-Q filingAug 13, 2026
- Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementMay 20, 2026
- 10-Q filingMay 14, 2026
Registered securities in this filing
cbdMD, INC. · 8-K · Filed 2026-04-15
Disclosure sections
Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events.
On April 14, 2026, the board of directors (the “Board”) of cbdMD, Inc. (the “Company”) issued each independent director and the non-management employee director 1,572 of the Company restricted stock units (the “RSUs”) as compensation for services as a director for the term beginning on March 31, 2026. The RSUs shall vest quarterly on June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027 and were granted under the Company’s 2025 Equity Compensation Plan. The value of restricted common stock issued is based on the closing price of the common stock as reported by the NYSE American LLC on April 14, 2026.
The Board also approved the following annual fees to the independent directors: (i) annual cash retainer of $35,000 payable monthly for each independent director, (ii) an additional $26,500 for the Chairman of the Board, $17,000 for the Chairman of the Audit Committee and $7,000 for the Chairman of the Compensation, Corporate Governance and Nominating Committee, and (iii) an additional $8,500 to the Audit Committee members (excluding chairperson) and $4,000 to the Compensation, Corporate Governance and Nominating Committee members (excluding chairperson).